Interventions to help bone density  |  Why & how to measure bone density  | References

References to bone health advice pages:

screen-shot-2017-02-22-at-17-40-56Rendina E et al. Dried plum’s capacity to reverse bone loss and alter bone metabolism in post menopausal osteoporosis model. Plos one,

Droke E et al. Soy isoflavones avert chronic inflammation-induced bone loss and vascular disease. J Inflammation 2007; 4(17).

 Garrett R et al. Oxygen-derived free radicals stimulate osteoclastic bone resorption in rodent bone in vitro and in vivo.J Clin Invest. 1990; 85(3):632-9.

 Hardcastle AC et al. Associations between dietary flavonoid intakes and bone health in a Scottish population.J Bone Miner Res. 201; 26(5):941-7.

Sacco SM et al. Phytonutrients for bone health during ageing. Br J Clin Pharmacol. 2013; 75(3):697-707.

Hubert P et al Dietary Polyphenols, Berries, and Age-Related Bone Loss: A Review Based on Human, Animal, and Cell Studies Antioxidants (Basel), 2014 ; 3(1): 144–158.

 Trzeciakiewicz A et al When nutrition interacts with osteoblast function: molecular mechanisms of polyphenols. Nutr Res Rev. 2009; 22(1):68-81.

 Shen Chwan-Li et al Green Tea and Bone metabolism. Nutr Res. 2009; 29(7): 437-56

Wright LE, et al. Protection of trabecular bone in ovariectomized rats by turmeric (Curcuma longa L.) is dependent on extract composition.. Journal of Agricultural and Food Chemistry. 2010;58(17):9498–504.

Kim W et al. Curcumin protects against ovariectomy-induced bone loss and decreases osteoclast activity. J Cell Biochem 112:3159-99.

Nair R et al. vitamin D; the Sunshine vitamin. J Pharmacol pharmacother 2012; 3(2): 118-126

Catiglioni S et al Magnesium and Osteoporosis: Current State of Knowledge and Future Research Directions. Nutrients 2013; 5(8): 3022–3033.

Saltman P et al The role of trace minerals in osteoporosis. J Am Coll Nutr. 1993; 12(4):384-9.

Gür A The role of trace minerals in the pathogenesis of postmenopausal osteoporosis and a new effect of calcitonin. J Bone Miner Metab. 2002; 20(1):39-43

Eaton-Evans J et al. Osteoporosis and the role of diet Br Journal Biomed Sci 1994;51(4):358-70.

Kurnatowska I et al. Effect of vitamin K2 on progression of atherosclerosis and vascular calcification in nondialyzed patients with chronic kidney disease. Pol Arch Med Wewn. 2015;125(9):631-40.

Shea MK, and Holden RM. Vitamin K status and vascular calcification: Evidence from observational and clinical studies. Adv Nutr. 2012;3(2):158-165. doi: 10.3945/an.111.001644.

Chiang S et al. Antiosteoporotic effects of Lactobacillus -fermented soy skim milk on bone mineral density and the microstructure of femoral bone in ovariectomized mice. J Agric Food Chem. 2011, 27; 59(14):7734-42.

Yacon F et al. Bifidobacterium longum modulate bone health in rats. J Med Food. 2012; 15(7):664-70.

Ohlsson C et al Probiotics protect mice from ovariectomy-induced cortical bone loss. PLoS One. 2014; 17; 9(3):e92368.

Reid G et al. New scientific paradigms for probiotics and prebiotics. J Clin Gastroenterol. 2003; 37(2):105-18.

Tsukamoto Y et al Intake of fermented soybean (natto) increases circulating Vitamin K2 and gamma-caboxylated osteocalcin concentrations in normal individuals. J Bone Miner Metab (2000) 18:216-222.

Caraballo PJ, Heit JA, Atkinson EJ, Silverstein MD, O’Fallon WM, Castro MR, Melton LJ III (1999) Long-term use of oral anticoagulants and the risk of fracture. Arch Intern Med 159: 1750–1756.

Hodges SJ, et al. Circulating levels of vitamins K1 and K2 decreased in elderly women with hip fracture. J Bone Miner Res 1993; 8:1241– 1245.

Jie K-SG, Bots ML, Vermeer C, Witteman JCM, Grobbee DE (1995) Vitamin K intake and osteocalcin levels in women with and without aortic atherosclerosis: a population-based study. Athero- sclerosis 116:117–123.

Shanahan CM, et al (1999) Medial localization of mineralization- regulating proteins in association with Mönckeberg’s sclerosis. Circulation 100:2168–2176.

Yamaguchi M Effect of vitamin K2 in fermented soybean (natto) on bone loss in ovariectomised rats. J Bone Miner Metab 17:23-29.

Beulens JW, Bots ML et al. High dietary menaquinone intake is associated with reduced coronary calcification. Atherosclerosis. 2009 Apr;203(2):489–493.

Geleijnse JM, Vermeer C et al. Dietary intake of menaquinone is associated with a reduced risk of coronary heart disease: The Rotterdam Study. J Nutr. 2004;134(11):3100-3105.

Harshman SG, and Shea MK. The role of vitamin K in chronic aging diseases: Inflammation, cardiovascular disease, and osteoarthritis. Curr Nutr Rep. 2016;5(2):90-98.

Tai V et al calcium and vitamin D supplements and bone health – a metanalyisis of randomized trials BMJ 2015; 351:h4183.

Bollard et al Calcium supplements and the coronary arterial disease – a meta-analysis of randomized trials BMJ 2010; 341:c3691.

Prieto-Alhambra D et al. Vitamin D threshold to prevent aromatase inhibitor-induced arthralgia: a prospective cohort study. Breast cancer Res Treat 2011;125(3):869-78

Datta M et al Calcium and Vitamin D Supplementation and Loss of Bone Mineral Density in Women Undergoing Breast Cancer Therapy. Crit Rev Oncol Hematol 2013; 88(3)

Lazzeroni M, Serrano D, Pilz S, et al. Vitamin D supplementation and cancer: review of randomized controlled trials. Anticancer Agents Med Chem 2013;13(1):118-125.

Schwartz G.G. Vitamin D, sunlight and the epidemiology of prostate cancer. Anti-Cancer Agent Me 2013;13(1):45-57.

Chiang KC and Chen TC. The Anti-cancer Actions of Vitamin D. Anticancer Agents Med Chem 2013;13(1):126-39.

Zgaga L et al. Plasma Vitamin D Concentration Influences Survival Outcome After a Diagnosis of Colorectal Cancer. JCO 2014;32(23):2430-2439.

Ng K et al. Circulating 25-Hydroxyvitamin D Levels and Survival in Patients with Colorectal Cancer. JCO 2008;26(18):2984-2991.

Rose AA et al. Blood levels of vitamin D and early stage breast cancer prognosis: a systematic review and meta-analysis. BJC 2001;85(10):1504–1509.

Mondul AM, et al. Circulating 25-Hydroxyvitamin D and Prostate Cancer Survival. Cancer Epidemiol Biomarkers Prev 2016; 25(4):665-9.

Pilz S et al. Vitamin D and cancer mortality: systematic review of prospective epidemiological studies. Anti-Cancer Agent Me 2013;13(1):107-117.

Giovannucci E. Epidemiology of vitamin d and colorectal cancer. Anticancer Agents Med Chem 2013;13(1):11-19.

Luscome C et al. Prostate cancer risk: associations with ultraviolet radiation, tyrosinase and melanocortin-1 receptor genotypes. Breast Cancer Res Treat 2013;141(3):331-339.

van der Rhee H, Coebergh JW and de Vries D. Is prevention of cancer by sun exposure more than just the effect of vitamin D? A systematic review of epidemiological studies. Eur J Cancer 2013;49(6):1422-1436.

Brown JK, Byers T, Doyle C, et al. Diet and physical activity during and after cancer treatment: An American cancer society guide for informed choices. CA Cancer J Clin 2003; 53(5): 268-291.

Twiss et al., 2001, Mackay & Joy 2005, Tanna N. Nurs Times 2009;105:28)

Waltman NL et al.; The effect of weight training on bone mineral density and bone turnover in postmenopausal breast cancer survivors with bone loss: A 24-month randomized controlled trial. Osteoporos Int 2010; 21(8): 1361-1369.

McTiernan A, and Wactawski-Wende J. (2009). Low-fat, increased fruit, vegetable, and grain dietary pattern, fractures, and bone mineral density: the Women’s Health Initiative Dietary Modification Trial. Am J Clin Nutr 89(6): 1864-76.

McNeeley M, Campbell K, Rowe B et al (2006) Effects of exercise on breast cancer patients and survivours: A systemic review and meta-analysis. Canadian Medical Association Journal 175:34-41.

Saad F, Adachi JD, Brown JP et al. Cancer Treatment – Induced Bone Loss in Breast Cancer and Prostate Cancer. J Clin Oncol 2008;26:5465-76.

The RECORD Trial Group. Oral vitamin D3 and calcium for secondary prevention of low-trauma fractures in elderly people (Randomised Evaluation of Calcium Or vitamin D, RECORD): a randomised placebo-controlled trial. The Lancet 2005, 365 (9471; 1621-28

Andersen BN, Johansen PB, Abrahamsen B. Proton pump inhibitors and osteoporosis. Curr. Opin. Rheumatol. 28(4):420–425, 2016.

Gomm W, von Holt K, Thomé F, et al. Association of proton pump inhibitors with risk of dementia: A pharmacoepidemiological claims database analysis. JAMA Neurol. 73(4): 410–416, 2016.

Ito T, Jensen RT. Association of long-term proton pump inhibitor therapy with bone fractures and effects on absorption of calcium, vitamin B12, iron and magnesium. Curr. Gastroenterol. Rep. 2010;12(6):448–57,